Merck & Co., Inc. (MRK) Deferred Tax Assets, Net of Valuation Allowance USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Merck & Co., Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from 2010 to 2023.
  • Merck & Co., Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $3.94B, a 30.6% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.94B +$922M +30.6% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $3.02B +$745M +32.8% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $2.27B -$163M -6.7% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $2.43B +$182M +8.09% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $2.25B +$481M +27.2% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $1.77B -$225M -11.3% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $2B -$1.11B -35.8% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $3.11B +$157M +5.32% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $2.95B -$568M -16.1% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $3.52B +$462M +15.1% Dec 31, 2014 10-K 2016-02-26
Q4 2013 $3.06B -$1.82B -37.3% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $4.88B -$651M -11.8% Dec 31, 2012 10-K 2014-02-27
Q4 2011 $5.53B +$194M +3.64% Dec 31, 2011 10-K 2013-02-28
Q4 2010 $5.33B Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.